Larvol Delta - Viracta-Therapeutics-Announces-Orphan-Drug-Designation-Granted-by-the-US-FDA-to-Nanaval-for-the-Treatment-of-Nasopharyngeal-Carcinoma

Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe

nanatinostat (VRx-3996) - Viracta Therap

https://www.globenewswire.com/news-release/2023/12/12/2794693/0/en/Viracta-Therapeutics-Announces-Orphan-Drug-Designation-Granted-by-the-U-S-FDA-to-Nana-val-for-the-Treatment-of-Nasopharyngeal-Carcinoma.html

Dec 12, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next